Eli Lilly
Recent developments from Eli Lilly summarized
Published in Physician Law Weekly, August 8th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Eli Lilly.
Report 1: Data from a recent clinical study showed Strattera(R) (atomoxetine HCl) improved symptoms of Attention- Deficit/Hyperactivity Disorder (ADHD) in patients with comorbid alcohol abuse disorder, suggesting ADHD can be treated safely and effectively with Strattera in patients with both disorders. Results from the 12-week study were presented today at a major medical meeting of psychiatrists.
The study was designed to test the hypothesis that Strattera is superior to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2007-08-08)
More Articles from Physician Law Weekly
- Aarp
Divided We Fail: Capitol Hill Advocacy Day - Abt Associates
Jacob A. Klerman Joins Abt Associates as a Principal Associate in Social and Economic Policy and Abt Associates Fellow - Addiction Medicine
ADA Applauds Legislators for 'Meth Mouth' Bills - Addiction Medicine
Research from DePaul University yields new findings on addiction medicine - Affymetrix Inc.
Children's Hospital of Philadelphia Selects Affymetrix SNP Array 6.0 for Series of Whole-genome Association Studies across 7,000 Samples - Aging
First-Annual Aging Revolution Summit to Address a New Model for Aging Services - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
